open access

Vol 89, No 1 (2021)
Letter to the Editor
Published online: 2021-01-29
Submitted: 2020-07-09
Accepted: 2020-08-08
Get Citation

Risk assessment and prognostic aspect of coagulopathy in COVID-19

Mujibur Rahman, Nadira Naznin Rakhi
DOI: 10.5603/ARM.a2020.0191
·
Pubmed: 33559122
·
Adv Respir Med 2021;89(1):90-91.

open access

Vol 89, No 1 (2021)
LETTERS
Published online: 2021-01-29
Submitted: 2020-07-09
Accepted: 2020-08-08

Abstract

Since December 2019, the rapid spread of SARS CoV-2 across the border, shuffled into a world pandemic situation with an alarming rate of morbidity and mortality. Concerns are mounting as the reports indicate tangled circumstances among the COVID-19 patients due to blood coagulopathy followed by organ dysfunction. COVID-19 induced an alteration in coagulation function increase the risk of pulmonary embolism and deep vein thrombosis associated with poor prognosis as well as high mortality. An elevated level D-dimer and other fibrin degrading protein are documented among the patients with COVID-19; especially in severe cases. Differences in coagulopathy among severe and non-severe cases, required prompt attention to adopt a more effective management strategy.

Abstract

Since December 2019, the rapid spread of SARS CoV-2 across the border, shuffled into a world pandemic situation with an alarming rate of morbidity and mortality. Concerns are mounting as the reports indicate tangled circumstances among the COVID-19 patients due to blood coagulopathy followed by organ dysfunction. COVID-19 induced an alteration in coagulation function increase the risk of pulmonary embolism and deep vein thrombosis associated with poor prognosis as well as high mortality. An elevated level D-dimer and other fibrin degrading protein are documented among the patients with COVID-19; especially in severe cases. Differences in coagulopathy among severe and non-severe cases, required prompt attention to adopt a more effective management strategy.

Get Citation

Keywords

COVID-19; blood coagulopathy; D-dimer; embolism; thrombosis

About this article
Title

Risk assessment and prognostic aspect of coagulopathy in COVID-19

Journal

Advances in Respiratory Medicine

Issue

Vol 89, No 1 (2021)

Article type

Letter to the Editor

Pages

90-91

Published online

2021-01-29

DOI

10.5603/ARM.a2020.0191

Pubmed

33559122

Bibliographic record

Adv Respir Med 2021;89(1):90-91.

Keywords

COVID-19
blood coagulopathy
D-dimer
embolism
thrombosis

Authors

Mujibur Rahman
Nadira Naznin Rakhi

References (10)
  1. Shanlian L. Index @ Www.Who.Int. Bull World Health Organ. Published online 2018: 817-908. .
  2. Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020; 18(7): 1738–1742.
  3. Xiong Mi, Liang X, Wei YD. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Br J Haematol. 2020; 189(6): 1050–1052.
  4. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  5. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, china. JAMA Intern Med. 2020; 180(7): 934–943.
  6. Guan WJ, Ni ZY, Hu Yu, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–1720.
  7. Snijders D, Schoorl M, Schoorl M, et al. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. Eur J Intern Med. 2012; 23(5): 436–441.
  8. Fogarty H, Townsend L, Ni Cheallaigh C, et al. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020; 189(6): 1044–1049.
  9. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e195S–e226S.
  10. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and cardiovascular disease. Circulation. 2020; 141(20): 1648–1655.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl